Terms: = Endocrine gland cancer AND TFG, TF6, 10342, ENSG00000114354, Q92734
23 results:
1. [Not Available].
Højsager KD; Kobberø H; Santoni-Rugiu E; Land LH; Sørensen JB
Ugeskr Laeger; 2024 Jan; 186(3):. PubMed ID: 38305267
[TBL] [Abstract] [Full Text] [Related]
2. Gene fusions are frequent in ACTH-secreting neuroendocrine neoplasms of the pancreas, but not in their non-pancreatic counterparts.
Agaimy A; Kasajima A; Stoehr R; Haller F; Schubart C; Tögel L; Pfarr N; von Werder A; Pavel ME; Sessa F; Uccella S; La Rosa S; Klöppel G
Virchows Arch; 2023 Mar; 482(3):507-516. PubMed ID: 36690805
[TBL] [Abstract] [Full Text] [Related]
3. Case Report: Giant Thyroid Angiolipoma-Challenging Clinical Diagnosis and Novel Genetic Alterations.
Wilkins R; Zan E; Leonardi O; Patel KN; Jacobson AS; Jour G; Liu CZ; Zhou F
Head Neck Pathol; 2023 Mar; 17(1):246-252. PubMed ID: 36255668
[TBL] [Abstract] [Full Text] [Related]
4. [Comparison of the methods for detecting NTRK gene fusion variations in papillary thyroid carcinoma].
Jiang YY; Chen H; Xu BL; Wang S
Zhonghua Bing Li Xue Za Zhi; 2022 Aug; 51(8):726-732. PubMed ID: 35922162
[No Abstract] [Full Text] [Related]
5. Molecular Characterization of Inflammatory Tumors Facilitates Initiation of Effective Therapy.
Wachter F; Al-Ibraheemi A; Trissal MC; Hollowell M; DuBois SG; Collins NB; Church AJ; Janeway KA
Pediatrics; 2021 Dec; 148(6):. PubMed ID: 34814185
[TBL] [Abstract] [Full Text] [Related]
6. Secretory Carcinoma of the Salivary gland: A Rarity in Children.
Kelly GA; Venkatramani R; Quintanilla NM; Chelius DC; Roy A; Mahajan P
J Pediatr Hematol Oncol; 2022 May; 44(4):167-172. PubMed ID: 34486543
[TBL] [Abstract] [Full Text] [Related]
7. Sclerosing Polycystic Adenoma: Conclusive Clinical and Molecular Evidence of Its Neoplastic Nature.
Hernandez-Prera JC; Saeed-Vafa D; Heidarian A; Gewandter K; Otto K; Wenig BM
Head Neck Pathol; 2022 Jun; 16(2):416-426. PubMed ID: 34410594
[TBL] [Abstract] [Full Text] [Related]
8. Clinicopathologic features of kinase fusion-related thyroid carcinomas: an integrative analysis with molecular characterization.
Chu YH; Wirth LJ; Farahani AA; Nosé V; Faquin WC; Dias-Santagata D; Sadow PM
Mod Pathol; 2020 Dec; 33(12):2458-2472. PubMed ID: 32737449
[TBL] [Abstract] [Full Text] [Related]
9. Proteogenomics analysis unveils a tfg-RET gene fusion and druggable targets in papillary thyroid carcinomas.
Krishnan A; Berthelet J; Renaud E; Rosigkeit S; Distler U; Stawiski E; Wang J; Modrusan Z; Fiedler M; Bienz M; Tenzer S; Schad A; Roth W; Thiede B; Seshagiri S; Musholt TJ; Rajalingam K
Nat Commun; 2020 Apr; 11(1):2056. PubMed ID: 32345963
[TBL] [Abstract] [Full Text] [Related]
10. Identification of key lncRNAs in the tumorigenesis of intraductal pancreatic mucinous neoplasm by coexpression network analysis.
Ding J; Li Y; Zhang Y; Fan B; Li Q; Zhang J; Zhang J
Cancer Med; 2020 Jun; 9(11):3840-3851. PubMed ID: 32239802
[TBL] [Abstract] [Full Text] [Related]
11. Novel TG-FGFR1 and TRIM33-NTRK1 transcript fusions in papillary thyroid carcinoma.
Pfeifer A; Rusinek D; Żebracka-Gala J; Czarniecka A; Chmielik E; Zembala-Nożyńska E; Wojtaś B; Gielniewski B; Szpak-Ulczok S; Oczko-Wojciechowska M; Krajewska J; Polańska J; Jarząb B
Genes Chromosomes Cancer; 2019 Aug; 58(8):558-566. PubMed ID: 30664823
[TBL] [Abstract] [Full Text] [Related]
12. Rapid Growth and Early Metastasis of Papillary Thyroid Carcinoma in an Adolescent Girl with Graves' Disease.
Shimura K; Shibata H; Mizuno Y; Amano N; Hoshino K; Kuroda T; Kameyama K; Matsuse M; Mitsutake N; Sugino K; Yoshimura Noh J; Hasegawa T; Ishii T
Horm Res Paediatr; 2019; 91(3):210-215. PubMed ID: 30092570
[TBL] [Abstract] [Full Text] [Related]
13. Clear Cell Change in Thyroid Carcinoma: A Clinicopathologic and Molecular Study with Identification of Variable Genetic Anomalies.
Cipriani NA; Agarwal S; Dias-Santagata D; Faquin WC; Sadow PM
Thyroid; 2017 Jun; 27(6):819-824. PubMed ID: 28293986
[TBL] [Abstract] [Full Text] [Related]
14. Identification of oncogenic mutations and gene fusions in the follicular variant of papillary thyroid carcinoma.
McFadden DG; Dias-Santagata D; Sadow PM; Lynch KD; Lubitz C; Donovan SE; Zheng Z; Le L; Iafrate AJ; Daniels GH
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2457-62. PubMed ID: 25148236
[TBL] [Abstract] [Full Text] [Related]
15. Identification of differentially expressed genes using an annealing control primer system in stage III serous ovarian carcinoma.
Kim YS; Hwan JD; Bae S; Bae DH; Shick WA
BMC Cancer; 2010 Oct; 10():576. PubMed ID: 20969748
[TBL] [Abstract] [Full Text] [Related]
16. Rearrangements of NTRK1 gene in papillary thyroid carcinoma.
Greco A; Miranda C; Pierotti MA
Mol Cell Endocrinol; 2010 May; 321(1):44-9. PubMed ID: 19883730
[TBL] [Abstract] [Full Text] [Related]
17. Analysis of SHP-1-mediated down-regulation of the TRK-T3 oncoprotein identifies Trk-fused gene (tfg) as a novel SHP-1-interacting protein.
Roccato E; Miranda C; Raho G; Pagliardini S; Pierotti MA; Greco A
J Biol Chem; 2005 Feb; 280(5):3382-9. PubMed ID: 15557341
[TBL] [Abstract] [Full Text] [Related]
18. Antitumor activity of expanded human tumor-infiltrating gammadelta T lymphocytes.
Chen J; Niu H; He W; Ba D
Int Arch Allergy Immunol; 2001 Jul; 125(3):256-63. PubMed ID: 11490159
[TBL] [Abstract] [Full Text] [Related]
19. Chromosome 1 rearrangements involving the genes TPR and NTRK1 produce structurally different thyroid-specific TRK oncogenes.
Greco A; Miranda C; Pagliardini S; Fusetti L; Bongarzone I; Pierotti MA
Genes Chromosomes Cancer; 1997 Jun; 19(2):112-23. PubMed ID: 9172002
[TBL] [Abstract] [Full Text] [Related]
20. Characterization and chromosomal mapping of the human tfg gene involved in thyroid carcinoma.
Mencinger M; Panagopoulos I; Andreasson P; Lassen C; Mitelman F; Aman P
Genomics; 1997 May; 41(3):327-31. PubMed ID: 9169129
[TBL] [Abstract] [Full Text] [Related]
[Next]
